×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
CausalMutation
disease
CLINVAR
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
Biomarker
disease
MGD
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
63924
Gene Symbol:
CIDEC
CIDEC
0.300
Biomarker
disease
CTD_human
×
Entrez Id:
5346
Gene Symbol:
PLIN1
PLIN1
0.300
Biomarker
disease
CTD_human
×
Entrez Id:
3991
Gene Symbol:
LIPE
LIPE
0.300
Biomarker
disease
CTD_human
ZMPSTE24
0.200
Biomarker
disease
MGD
HNRNPUL2-BSCL2
0.100
GeneticVariation
disease
CLINVAR
×
Entrez Id:
26580
Gene Symbol:
BSCL2
BSCL2
0.100
GeneticVariation
disease
CLINVAR
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
BEFREE
A novel PPARG mutation leading to FPLD3 is described.
26119484
2016
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
UNIPROT
A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
11788685
2002
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GermlineCausalMutation
disease
ORPHANET
A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy.
11788685
2002
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
Biomarker
disease
CTD_human
Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy.
19793595
2009
×
Entrez Id:
857
Gene Symbol:
CAV1
CAV1
0.300
Biomarker
disease
CTD_human
Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy.
19793595
2009
×
Entrez Id:
4000
Gene Symbol:
LMNA
LMNA
0.300
Biomarker
disease
CTD_human
Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy.
19793595
2009
×
Entrez Id:
208
Gene Symbol:
AKT2
AKT2
0.300
Biomarker
disease
CTD_human
Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy.
19793595
2009
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
CLINVAR
Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.
10622252
2000
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
CLINVAR
Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.
15254591
2004
×
Entrez Id:
4000
Gene Symbol:
LMNA
LMNA
0.300
Biomarker
disease
CTD_human
Lack of mutations in LMNA, its promoter region, and the cellular retinoic acid binding protein II (CRABP II) in HIV associated lipodystrophy.
12844477
2003
×
Entrez Id:
4000
Gene Symbol:
LMNA
LMNA
0.300
Biomarker
disease
CTD_human
Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone.
16241930
2005
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
Biomarker
disease
BEFREE
Moreover, PPARgamma haplo-insufficiency also exists in human known as a rare disease (FPLD3 ) causing metabolic adverse effects, similar to the mouse.
29163553
2017
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
BEFREE
Patient 1 suffered for 18 years from devastating complications of undiagnosed type 3 familial partial lipodystrophy due to a deleterious heterozygous variant in PPARG .
31000363
2019
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
CLINVAR
Peroxisome proliferator-activated receptor-γ protects against vascular aging.
22461176
2012
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GeneticVariation
disease
UNIPROT
PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.
12453919
2002
×
Entrez Id:
5468
Gene Symbol:
PPARG
PPARG
0.980
GermlineCausalMutation
disease
ORPHANET
PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.
12453919
2002